• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

传统草药衍生的萝卜硫素LFS-01通过选择性改变肠道微生物群和促进肠道γδT细胞来逆转小鼠结肠炎。

Traditional Herbal Medicine-Derived Sulforaphene LFS-01 Reverses Colitis in Mice by Selectively Altering the Gut Microbiota and Promoting Intestinal Gamma-Delta T Cells.

作者信息

Li Ming, Gao Jiali, Tang Yan, Liu Meishuo, Wu Sijin, Qu Kunli, Long Xiangyu, Li Huajun, Liu Min, Liu Yinhui, Yuan Jieli, Mao Lei, Liu Yu, Zheng Xiliang, Wang Erkang, Wang Jin, Yang Yongliang

机构信息

Department of Microecology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.

Center for Molecular Medicine, School of Life Sciences and Biotechnology, Dalian University of Technology, Dalian, China.

出版信息

Front Pharmacol. 2018 Jan 9;8:959. doi: 10.3389/fphar.2017.00959. eCollection 2017.

DOI:10.3389/fphar.2017.00959
PMID:29375374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5767259/
Abstract

Sulforaphene (LFS-01) is a natural compound derived from traditional herbal medicine. Here, we show that oral administration of LFS-01 is able to dramatically alter the skewed gut microbiota and reverse colitis in model mice associated with an increase of intestinal γδT cells. Through 16S rDNA sequencing, we showed that LFS-01 can selectively suppress enteric pathogens such as and whereas the protective strains including and were significantly expanded after LFS-01 treatment. Interestingly, we demonstrated that LFS-01 administration can significantly promote the IL-17+γδT cells in model mice in response to the expanded . We verified that the intracellular components of can stimulate the growth of IL-17+γδT cells upon preincubation. The increased IL-17A after LFS-01 treatment in turn recovers the disrupted occludin subcellular location and protects the epithelial barrier in the colon of model mice. Remarkably, LFS-01 does not show apparent toxicity to animals and we demonstrated that LFS-01 also exerts strong protective effects in TNBS-induced colitis rats. Therefore, LFS-01 holds great promise for the treatment of inflammatory bowel disease (IBD) and warrants translation for use in clinical trials. Our work provided a new avenue for the treatment of IBD based on the strategy of harnessing intestinal symbiosis.

摘要

萝卜硫素(LFS - 01)是一种源自传统草药的天然化合物。在此,我们表明口服LFS - 01能够显著改变模型小鼠中失衡的肠道微生物群,并逆转与肠道γδT细胞增加相关的结肠炎。通过16S rDNA测序,我们发现LFS - 01可以选择性抑制诸如[具体病原体1]和[具体病原体2]等肠道病原体,而包括[具体有益菌1]和[具体有益菌2]在内的保护性菌株在LFS - 01处理后显著增加。有趣的是,我们证明给予LFS - 01能够显著促进模型小鼠中IL - 17 + γδT细胞对扩增的[具体有益菌]的反应。我们证实,[具体有益菌]的细胞内成分在预孵育后能够刺激IL - 17 + γδT细胞的生长。LFS - 01处理后IL - 17A的增加反过来恢复了模型小鼠结肠中被破坏的闭合蛋白亚细胞定位,并保护了上皮屏障。值得注意的是,LFS - 01对动物未表现出明显毒性,并且我们证明LFS - 01在三硝基苯磺酸(TNBS)诱导的结肠炎大鼠中也发挥了强大的保护作用。因此,LFS - 01在治疗炎症性肠病(IBD)方面具有巨大潜力,值得转化用于临床试验。我们的工作为基于利用肠道共生策略治疗IBD提供了一条新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/4b4baa900989/fphar-08-00959-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/3067c356f504/fphar-08-00959-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/5078dba50093/fphar-08-00959-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/dd1bc418d0d8/fphar-08-00959-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/e198516e1840/fphar-08-00959-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/0ad4f982d10f/fphar-08-00959-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/d554cf7ad926/fphar-08-00959-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/9734babb7099/fphar-08-00959-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/4b4baa900989/fphar-08-00959-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/3067c356f504/fphar-08-00959-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/5078dba50093/fphar-08-00959-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/dd1bc418d0d8/fphar-08-00959-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/e198516e1840/fphar-08-00959-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/0ad4f982d10f/fphar-08-00959-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/d554cf7ad926/fphar-08-00959-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/9734babb7099/fphar-08-00959-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d442/5767259/4b4baa900989/fphar-08-00959-g008.jpg

相似文献

1
Traditional Herbal Medicine-Derived Sulforaphene LFS-01 Reverses Colitis in Mice by Selectively Altering the Gut Microbiota and Promoting Intestinal Gamma-Delta T Cells.传统草药衍生的萝卜硫素LFS-01通过选择性改变肠道微生物群和促进肠道γδT细胞来逆转小鼠结肠炎。
Front Pharmacol. 2018 Jan 9;8:959. doi: 10.3389/fphar.2017.00959. eCollection 2017.
2
Upregulation of Intestinal Barrier Function in Mice with DSS-Induced Colitis by a Defined Bacterial Consortium Is Associated with Expansion of IL-17A Producing Gamma Delta T Cells.特定细菌群落对葡聚糖硫酸钠诱导的结肠炎小鼠肠道屏障功能的上调作用与产生白细胞介素-17A的γδT细胞扩增有关。
Front Immunol. 2017 Jul 12;8:824. doi: 10.3389/fimmu.2017.00824. eCollection 2017.
3
Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.不同乳酸杆菌和双歧杆菌菌株预防三硝基苯磺酸诱导的结肠炎与肠道上皮内淋巴细胞的γδT细胞和调节性T细胞扩增有关。
Inflamm Bowel Dis. 2009 Oct;15(10):1526-36. doi: 10.1002/ibd.20961.
4
Traditional herbal medicine-derived sulforaphene promotes mitophagic cell death in lymphoma cells through CRM1-mediated p62/SQSTM1 accumulation and AMPK activation.传统草药来源的萝卜硫素通过CRM1介导的p62/SQSTM1积累和AMPK激活促进淋巴瘤细胞的线粒体自噬性细胞死亡。
Chem Biol Interact. 2018 Feb 1;281:11-23. doi: 10.1016/j.cbi.2017.12.017. Epub 2017 Dec 13.
5
Micro Integral Membrane Protein (MIMP), a Newly Discovered Anti-Inflammatory Protein of Lactobacillus Plantarum, Enhances the Gut Barrier and Modulates Microbiota and Inflammatory Cytokines.微小整合膜蛋白(MIMP)是植物乳杆菌新发现的一种抗炎蛋白,可增强肠道屏障并调节微生物群和炎性细胞因子。
Cell Physiol Biochem. 2018;45(2):474-490. doi: 10.1159/000487027. Epub 2018 Jan 25.
6
Interleukin 1α-Deficient Mice Have an Altered Gut Microbiota Leading to Protection from Dextran Sodium Sulfate-Induced Colitis.白细胞介素-1α缺陷小鼠的肠道微生物群发生改变,从而对葡聚糖硫酸钠诱导的结肠炎具有保护作用。
mSystems. 2018 May 8;3(3). doi: 10.1128/mSystems.00213-17. eCollection 2018 May-Jun.
7
Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis.肠内递送再生家庭成员 3α可改变结肠炎小鼠的肠道微生物群并控制炎症。
Gastroenterology. 2018 Mar;154(4):1009-1023.e14. doi: 10.1053/j.gastro.2017.11.003. Epub 2017 Nov 11.
8
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.炎症、营养供应和共生微生物群在肠道病原体感染中的作用。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
9
New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.通过结合体外和体内方法鉴定出用于炎症性肠病管理的新型益生菌菌株。
Benef Microbes. 2018 Feb 27;9(2):317-331. doi: 10.3920/BM2017.0097.
10
Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats by Keap1/Nrf-2 Activation, Intestinal Barrier Function, and Gut Microbiota Regulation.通过激活Keap1/Nrf-2、改善肠道屏障功能和调节肠道微生物群来减轻硫酸葡聚糖钠诱导的大鼠溃疡性结肠炎。
Front Pharmacol. 2018 Aug 22;9:944. doi: 10.3389/fphar.2018.00944. eCollection 2018.

引用本文的文献

1
Probiotic Fermentation of and Raphani Semen Ameliorates Cyclophosphamide-Induced Immunosuppression Through Intestinal Short-Chain Fatty Acid-Dependent or -Independent Regulation of B Cell Function.莱菔子的益生菌发酵通过肠道短链脂肪酸依赖性或非依赖性调节B细胞功能改善环磷酰胺诱导的免疫抑制。
Biology (Basel). 2025 Mar 19;14(3):312. doi: 10.3390/biology14030312.
2
Radish Seed Exerts Anti-Diabetic and Obesity-Reducing Effects in Mice by Promoting the Activation of Uncoupling Protein 1 and Peroxisome Proliferator-Activated Receptor-γ Coactivator 1-α.萝卜籽通过促进解偶联蛋白1和过氧化物酶体增殖物激活受体γ辅激活因子1-α的激活,对小鼠发挥抗糖尿病和减轻肥胖的作用。
J Evid Based Integr Med. 2025 Jan-Dec;30:2515690X251316760. doi: 10.1177/2515690X251316760.
3

本文引用的文献

1
High-affinity monoclonal IgA regulates gut microbiota and prevents colitis in mice.高亲和力单克隆 IgA 调节肠道微生物群并预防小鼠结肠炎。
Nat Microbiol. 2016 Jul 4;1(9):16103. doi: 10.1038/nmicrobiol.2016.103.
2
Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring.微生物重建可逆转母体饮食诱导的后代社交和突触缺陷。
Cell. 2016 Jun 16;165(7):1762-1775. doi: 10.1016/j.cell.2016.06.001.
3
Helminth infection promotes colonization resistance via type 2 immunity.蠕虫感染通过2型免疫促进定植抗性。
Postoperative Tongqi Formula ameliorates postoperative ileus via p38 MAPK signaling pathway and metabolic disorder.术后通气方通过p38丝裂原活化蛋白激酶信号通路和代谢紊乱改善术后肠梗阻。
Heliyon. 2024 Dec 13;11(1):e41217. doi: 10.1016/j.heliyon.2024.e41217. eCollection 2025 Jan 15.
4
Gut microbiota mediated T cells regulation and autoimmune diseases.肠道微生物群介导的T细胞调节与自身免疫性疾病。
Front Microbiol. 2024 Dec 19;15:1477187. doi: 10.3389/fmicb.2024.1477187. eCollection 2024.
5
Glucocorticoid-Induced Leucine Zipper Protein and Yeast-Extracted Compound Alleviate Colitis and Reduce Fungal Dysbiosis.糖皮质激素诱导的亮氨酸拉链蛋白和酵母提取物化合物可缓解结肠炎并减少真菌失调。
Biomolecules. 2024 Oct 17;14(10):1321. doi: 10.3390/biom14101321.
6
A Scoping Review on Hepatoprotective Mechanism of Herbal Preparations through Gut Microbiota Modulation.通过调节肠道菌群对草药制剂肝脏保护机制的范围综述
Curr Issues Mol Biol. 2024 Oct 16;46(10):11460-11502. doi: 10.3390/cimb46100682.
7
Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis.中药对肠道微生物群及微生物-肠-肝轴的调节作用
Front Pharmacol. 2024 Oct 9;15:1442854. doi: 10.3389/fphar.2024.1442854. eCollection 2024.
8
Combining Metagenomics, Network Pharmacology and RNA-Seq Strategies to Reveal the Therapeutic Effects and Mechanisms of Qingchang Wenzhong Decoction on Inflammatory Bowel Disease in Mice.运用宏基因组学、网络药理学和 RNA-Seq 策略揭示清肠温中汤治疗小鼠炎症性肠病的疗效及作用机制。
Drug Des Devel Ther. 2024 Sep 24;18:4273-4289. doi: 10.2147/DDDT.S473688. eCollection 2024.
9
Regulation of Gut Microbiota by Herbal Medicines.草药对肠道微生物群的调节。
Curr Drug Metab. 2024;25(2):110-127. doi: 10.2174/0113892002287336240328083220.
10
Anticancer properties of sulforaphane: current insights at the molecular level.萝卜硫素的抗癌特性:分子水平的当前见解
Front Oncol. 2023 Jun 16;13:1168321. doi: 10.3389/fonc.2023.1168321. eCollection 2023.
Science. 2016 Apr 29;352(6285):608-12. doi: 10.1126/science.aaf3229. Epub 2016 Apr 14.
4
Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells.共生微生物群通过调节肠道γδ T细胞影响缺血性中风的预后。
Nat Med. 2016 May;22(5):516-23. doi: 10.1038/nm.4068. Epub 2016 Mar 28.
5
Fungal microbiota dysbiosis in IBD.炎症性肠病中的真菌微生物群失调
Gut. 2017 Jun;66(6):1039-1048. doi: 10.1136/gutjnl-2015-310746. Epub 2016 Feb 3.
6
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability.不依赖白细胞介素-23的白细胞介素-17产生调节肠道上皮通透性。
Immunity. 2015 Oct 20;43(4):727-38. doi: 10.1016/j.immuni.2015.09.003. Epub 2015 Sep 29.
7
The global burden of IBD: from 2015 to 2025.IBD 的全球负担:2015 年至 2025 年。
Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):720-7. doi: 10.1038/nrgastro.2015.150. Epub 2015 Sep 1.
8
Inhibition of Dectin-1 Signaling Ameliorates Colitis by Inducing Lactobacillus-Mediated Regulatory T Cell Expansion in the Intestine.Dectin-1 信号抑制通过诱导肠道中乳酸菌介导的调节性 T 细胞扩增来改善结肠炎。
Cell Host Microbe. 2015 Aug 12;18(2):183-97. doi: 10.1016/j.chom.2015.07.003.
9
Epidemiology and risk factors for IBD.炎症性肠病的流行病学和风险因素。
Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):205-17. doi: 10.1038/nrgastro.2015.34. Epub 2015 Mar 3.
10
Gut fungal microbiota: the Yin and Yang of inflammatory bowel disease.肠道真菌微生物群:炎症性肠病的阴阳两面
Inflamm Bowel Dis. 2015 Mar;21(3):656-65. doi: 10.1097/MIB.0000000000000261.